These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22103621)
1. Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia. Sumatoh HR; Oliver BG; Kumar M; Elliott JH; Vonthanak S; Vun MC; Singh S; Agarwal U; Kumar A; Tan HY; Kamarulzaman A; Yunihastuti E; Saraswati H; Price P Biomark Med; 2011 Dec; 5(6):847-53. PubMed ID: 22103621 [TBL] [Abstract][Full Text] [Related]
2. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078 [TBL] [Abstract][Full Text] [Related]
3. Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART. Yunihastuti E; Lee S; Gani RA; Saraswati H; Sundaru H; Lesmana LA; Sukmana N; Price P Clin Immunol; 2011 Apr; 139(1):32-9. PubMed ID: 21296026 [TBL] [Abstract][Full Text] [Related]
4. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. Oliver BG; Elliott JH; Price P; Phillips M; Saphonn V; Vun MC; Kaldor JM; Cooper DA; French MA J Infect Dis; 2010 Dec; 202(11):1728-37. PubMed ID: 20977362 [TBL] [Abstract][Full Text] [Related]
5. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. Tan DB; Lim A; Yong YK; Ponnampalavanar S; Omar S; Kamarulzaman A; French MA; Price P AIDS; 2011 Jul; 25(12):1455-60. PubMed ID: 21610488 [TBL] [Abstract][Full Text] [Related]
6. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177 [TBL] [Abstract][Full Text] [Related]
7. [Humoral immune response against mycobacterial antigens in patients with tuberculosis and mycobacterial infections other than tuberculosis]. Demkow U; Białas-Chromiec B; Filewska M; Zielonka T; Michałowska-Mitczuk D; Kuś J; Broniarek-Samson B; Augustynowicz-Kopeć E; Zwolska Z; Rowińska-Zakrzewska E Pneumonol Alergol Pol; 2006; 74(2):203-8. PubMed ID: 17269370 [TBL] [Abstract][Full Text] [Related]
8. Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study. Gennaro ML; Affouf M; Kanaujia GV; Brusasca PN; Mangura B; Reichman L Int J Tuberc Lung Dis; 2007 Jun; 11(6):624-31. PubMed ID: 17519093 [TBL] [Abstract][Full Text] [Related]
9. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea. Azzurri A; Kanaujia GV; Sow OY; Bah B; Diallo A; Del Prete G; Gennaro ML Int J Immunopathol Pharmacol; 2006; 19(1):199-208. PubMed ID: 16569358 [TBL] [Abstract][Full Text] [Related]
10. Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with Mycobacterium tuberculosis. Price P; Haddow LJ; Affandi J; Agarwal U; Easterbrook PJ; Elliott J; French M; Kumar M; Moosa MY; Oliver B; Singh S; Sola M; Saphonn V; Vun MC AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1216-9. PubMed ID: 22280097 [TBL] [Abstract][Full Text] [Related]
11. Humoral immune response against mycobacterial antigens in children with tuberculosis. Demkow U; Ziołkowski J; Białas-Chromiec B; Filewska M; Zielonka T; Wasik M; Rowińska-Zakrzewska E J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():63-73. PubMed ID: 17072031 [TBL] [Abstract][Full Text] [Related]
12. Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients. Simonney N; Dewulf G; Herrmann JL; Gutierrez MC; Vicaut E; Boutron C; Leportier M; Lafaurie M; Abgrall S; Sereni D; Autran B; Carcelain G; Bourgarit A; Lagrange PH Tuberculosis (Edinb); 2008 Sep; 88(5):453-61. PubMed ID: 18495539 [TBL] [Abstract][Full Text] [Related]
13. [Their titers and recognized molecules of IgG class anti-BCG antibody in sera from patients with tuberculosis]. Aoki A; Hagiwara E; Shirai A; Ishigatsubo Y; Kenji T; Okubo T; Yokota S; Yoshida H; Matsuyama S Nihon Kyobu Shikkan Gakkai Zasshi; 1990 May; 28(5):729-35. PubMed ID: 2214416 [TBL] [Abstract][Full Text] [Related]
14. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Seddiki N; Sasson SC; Santner-Nanan B; Munier M; van Bockel D; Ip S; Marriott D; Pett S; Nanan R; Cooper DA; Zaunders JJ; Kelleher AD Eur J Immunol; 2009 Feb; 39(2):391-403. PubMed ID: 19180462 [TBL] [Abstract][Full Text] [Related]
15. The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis. Affandi JS; Kumar M; Agarwal U; Singh S; Price P Dis Markers; 2013; 34(6):445-9. PubMed ID: 23594560 [TBL] [Abstract][Full Text] [Related]
16. Interferon-γ and IL-5 production correlate directly in HIV patients co-infected with mycobacterium tuberculosis with or without immune restoration disease. Oliver BG; Elliott JH; Saphonn V; Vun MC; French MA; Price P AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1287-9. PubMed ID: 20860531 [TBL] [Abstract][Full Text] [Related]
17. Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis. Hernández-Pando R; Reyes P; Espitia C; Wang Y; Rook G; Mancilla R J Rheumatol; 1994 Oct; 21(10):1870-6. PubMed ID: 7837153 [TBL] [Abstract][Full Text] [Related]